Loading
C the Signs
C the Signs is a health technology company focused on improving early cancer detection through its AI-powered clinical decision support platform. Founded in 2017 by NHS doctors Dr. Bea Bakshi and Dr. Miles Payling, the company aims to democratize access to early cancer detection for all patients. The platform analyzes patient data to identify those at risk of cancer and recommends appropriate diagnostic tests or specialist referrals in under 30 seconds. The Cancer Prediction System, the company's primary product, covers over 100 cancer types and integrates with Electronic Health Records (EHRs) to provide real-time support during medical consultations. C the Signs serves healthcare providers, clinicians, and health systems, including the UK's National Health Service. The platform is already in use in over 1,500 GP practices in the UK, helping more than 60,000 people receive earlier diagnoses. With a commitment to equity and universal access, C the Signs is expanding its reach to serve millions of patients globally.
Funding
Every round, secondary, debt facility or acquisition involving C the Signs that Lounge tracks, newest first.
No rounds recorded yet.
Paid members see the full deals desk — every AI round and exit, filterable by type, sector and country, with investors and reported ARR, plus CSV exports. Developer membership is $9/mo.
See plans →Log inKey numbers
—
0
—
—